EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Tranexamic Acid for Acute Upper Respiratory Tract Infection‐Associated Sore Throat Pain: A Randomized Controlled Trial

Naoto Ishimaru iD, Toshio Shimokawa, Masataka Ono, Shimpei Mizuki, Yohei Kanzawa, Takahiro Nakajima

Journal of General and Family Medicine · 2026-01 · 27 (1)

DOI: 10.1002/jgf2.70097 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of General and Family Medicine, online erschienen am 03.01.2026. Verfasst von Naoto Ishimaru und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Internal Medicine Akashi Medical Center Akashi Japan. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tranexamic acid (TXA) is sometimes used to relieve sore throat discomfort from acute upper‐respiratory tract infection (URTI), but its clinical effect has not been demonstrated in robust randomized controlled trials.

Methods

The tranexamic acid for URTI study is a randomized double‐blinded clinical trial that was conducted between November 2023 and March 2025. Patients with URTI and a sore throat (18–65 years old) were randomized to receive either 1 g placebo (lactose) or 1 g preparation of 50% TXA. Randomization was stratified according to age (< 45 vs. ≥ 45 years) and baseline sore throat visual analog scale (VAS) score (< 50 vs. ≥ 50). Change in the proportion of patients with sore throat score more than a moderate level within a 2‐h period after taking TXA was the primary outcome. We also examined the difference in sore throat VAS scale score between before and 2 h after TXA was taken. Data were analyzed using analysis of covariance, controlling for stratification factors.

Results

We analyzed the 17 participants assigned to each group (total = 34). The groups were not significantly different in the proportion of patients whose sore throat had a moderate or greater impact on their day‐to‐day life (TXA 41.2% vs. placebo 47.1%; p = 1.00). Similarly, they did not significantly differ in mean change of sore throat score on VAS within 30 min (TXA 17.3 vs. placebo 13.1; p = 0.49). No side effects were reported.

Conclusion

TXA was not significantly better than a placebo at relieving acute URTI‐associated sore throat. Trial Registration UMIN000056394

Schlagwörter

Stichwörter der Autor:innen

randomized controlled studysore throattranexamic acidupper‐respiratory tract infection

Autor:innen und Institutionen

  • Department of General Internal Medicine Akashi Medical Center Akashi Japan.
  • Clinical Research Center Takatsuki General Hospital Takatsuki Japan.
  • Clinical Study Support Center Wakayama Medical University Wakayama Japan.
  • Department of General Internal Medicine Kobe University Hospital Kobe Japan.

ORCID-Profile: Naoto Ishimaru

Zitieren

APA

Ishimaru, N., Shimokawa, T., Ono, M., Mizuki, S., Kanzawa, Y., & Nakajima, T. (2026). Tranexamic Acid for Acute Upper Respiratory Tract Infection‐Associated Sore Throat Pain: A Randomized Controlled Trial. Journal of General and Family Medicine, 27(1). https://doi.org/10.1002/jgf2.70097

Vancouver

Ishimaru N, Shimokawa T, Ono M, Mizuki S, Kanzawa Y, Nakajima T. Tranexamic Acid for Acute Upper Respiratory Tract Infection‐Associated Sore Throat Pain: A Randomized Controlled Trial. Journal of General and Family Medicine. 2026;27(1). doi:10.1002/jgf2.70097

BibTeX
@article{Ishimaru2026,
  author = {Ishimaru, Naoto and Shimokawa, Toshio and Ono, Masataka and Mizuki, Shimpei and Kanzawa, Yohei and Nakajima, Takahiro},
  title = {Tranexamic Acid for Acute Upper Respiratory Tract Infection‐Associated Sore Throat Pain: A Randomized Controlled Trial},
  journal = {Journal of General and Family Medicine},
  year = {2026},
  volume = {27},
  number = {1},
  doi = {10.1002/jgf2.70097}
}
Kostenlos starten →